Welcome to Richmond Behavioral Associates

Richmond Behavioral Associates is geared to treat patients with the latest advances in clinical psychopharmacology.

Dr. DiBuono’s and Dr Shalenberg’s expertise in psychiatric medications coupled with our experience in conducting clinical trials in Depression, Bipolar Disorder, Schizophrenia, Alzheimer’s Disease, Autism, and Anxiety have enabled our patients to obtain the latest medications for these disorders. We have conducted trials for all the major pharmaceutical companies including Allergan, Astra-Zeneca, Bristol Myers Squibb, Eli Lilly, Johnson and Johnson, Pfizer, Roche-Genentech, Sanofi-Aventis, just to name a few.

Richmond Behavioral Associates also prides itself as a treatment service first, and as such seeks to provide quality care with excellent patient follow up.

Focusing on the Patient

Given our extensive experience in treating acutely ill patients we have expertise in the following disorders:

  • Anxiety Disorders

  • Generalized Anxiety Disorder

  • Social Anxiety Disorder

  • Panic Attacks

  • Agoraphobia Major Depressive Disorders

  • Treatment Resistant Depression

  • Bipolar Disorder

  • Alzheimer Disease: Cognitive/ Behavioral

  • Schizophrenia

Why Richmond Behavioral Associates

  • Offer premier treatment with experienced pharmacologists.

  • Have access to state of the art interventions

  • Investigational medications prior to being available on the market.

Our Motto

The mind has great influence over the body and maladies often have their origin there.

— John Doe Molicere

Our Current Studies

Latest Articles on Clinical Trials at Richmond Behavioral Associates

  • Treatment Resistant Depression

    Treatment Resistant Depression

    Treatment Resistant Depression Major Depressive Disorder is one of the most acute, widespread pathologies of the 21st century, affecting nearly 15 million American adults annually(1). Patients…Read more

Meet The Team